$WYGC
Longwen Group Corp. Stock $wygc

$wygc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000101738623000399 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$21.09K	$548.9K	$11.33K
YoY Change	-3.39%	4745.08%
Cost Of Revenue	$2.200K	$550.1K
YoY Change
Gross Profit	$18.89K	-$1.265K	$11.33K
YoY Change		-111.17%
Gross Profit Margin	89.57%	-0.23%	100.0%
Selling, General & Admin	$1.021M	$125.8K	$21.38K
YoY Change	78.61%	488.31%
% of Gross Profit	5405.03%		188.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.950K	$6.340K	$1.330K
YoY Change	-4.84%	376.69%
% of Gross Profit	15.62%		11.74%
Operating Expenses	$1.033M	$187.6K	$51.39K
YoY Change	80.72%	265.01%
Operating Profit	-$1.014M	-$189.1K	-$40.30K
YoY Change		369.32%	32137.6%
Interest Expense	-$370.00	-$100.00	$125.00
YoY Change	184.62%	-180.0%	0.0%
% of Operating Profit
Other Income/Expense, Net	-$7.990K	-$170.00	-$110.00
YoY Change	-10087.5%	54.55%
Pretax Income	-$1.023M	-$189.1K	-$40.30K
YoY Change	85.97%	369.28%
Income Tax
% Of Pretax Income
Net Earnings	-$1.026M	-$189.1K	-$40.30K
YoY Change	86.68%	369.32%	32137.6%
Net Earnings / Revenue	-4867.05%	-34.46%	-355.73%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	-$0.01	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	79.83M shares	79.83M shares	65.76M shares
Diluted Shares Outstanding		79.83M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.45K	$5.640K	$272.1K
YoY Change	-72.92%	-97.93%
Cash & Equivalents	$18.45K	$5.638K	$272.1K
Short-Term Investments
Other Short-Term Assets	$526.2K	$13.70K	$83.07K
YoY Change	800.87%	-83.51%
Inventory	$40.37K	$39.30K
Prepaid Expenses	$45.63K	$13.70K	$83.07K
Receivables		$378.2K
Other Receivables		$0.00
Total Short-Term Assets	$585.0K	$436.8K	$355.2K
YoY Change	362.34%	22.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$254.6K	$250.4K	$269.0K
YoY Change	-7.21%	-6.92%
Goodwill	$1.132K	$1.132K	$993.00
YoY Change	0.0%	14.0%
Intangibles	$2.994K	$2.911K
YoY Change	-17.41%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$258.7K	$254.5K	$270.0K
YoY Change	-7.32%	-5.76%
TOTAL ASSETS
Total Short-Term Assets	$585.0K	$436.8K	$355.2K
Total Long-Term Assets	$258.7K	$254.5K	$270.0K
Total Assets	$843.7K	$691.3K	$625.2K
YoY Change	107.99%	10.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$119.5K	$483.1K
YoY Change	273.78%
Accrued Expenses			$1.680K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$283.0K	$230.2K	$289.9K
YoY Change	175.49%	-20.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$920.2K	$713.3K	$291.6K
YoY Change	583.09%	144.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$920.2K	$713.3K	$291.6K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$920.2K	$713.3K	$291.6K
YoY Change	583.09%	144.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.05M	-$19.96M	-$18.48M
YoY Change	5.39%	8.02%
Common Stock	$7.878K	$7.983K	$6.929K
YoY Change	6.3%	15.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$76.44K	-$22.04K	$333.6K
YoY Change
Total Liabilities & Shareholders Equity	$843.7K	$691.3K	$625.2K
YoY Change	107.99%	10.57%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.026M	-$189.1K	-$40.30K
YoY Change	86.68%	369.32%	32137.6%
Depreciation, Depletion And Amortization	$2.950K	$6.340K	$1.330K
YoY Change	-4.84%	376.69%
Cash From Operating Activities	-$74.59K	-$96.35K	-$276.1K
YoY Change	12.93%	-65.11%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$7.750K
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$10.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00	$0.00	-$7.750K
YoY Change	-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	88.19K	85.59K	577.2K
YoY Change	-158.59%	-85.17%
NET CHANGE
Cash From Operating Activities	-74.59K	-96.35K	-276.1K
Cash From Investing Activities	0.000	0.000	-7.750K
Cash From Financing Activities	88.19K	85.59K	577.2K
Net Change In Cash	13.60K	-10.76K	293.3K
YoY Change	-106.19%	-103.67%
FREE CASH FLOW
Cash From Operating Activities	-$74.59K	-$96.35K	-$276.1K
Capital Expenditures	$0.00	$0.00	$7.750K
Free Cash Flow	-$74.59K	-$96.35K	-$283.9K
YoY Change	13.31%	-66.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2022Q3	lwlw	Online Product Sales OnlineProductSales		usd
CY2022Q3	lwlw	Offline Product Sales OfflineProductSales		usd
CY2022Q3	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses		usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000723533
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	lwlw	Common Stock Issuable CommonStockIssuable		usd
CY2022Q4	lwlw	Deferred Compensation Sharebased DeferredCompensationSharebased		usd
CY2023Q3	lwlw	Consulting Service Income ConsultingServiceIncome		usd
CY2023Q3	lwlw	Online Product Sales OnlineProductSales		usd
	lwlw	Online Product Sales OnlineProductSales		usd
	lwlw	Offline Product Sales OfflineProductSales		usd
CY2023Q3	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses		usd
CY2022Q3	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses		usd
	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses		usd
	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	lwlw	Repayments Of Loans From Shareholder Loans RepaymentsOfLoansFromShareholderLoans		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Acquisition Costs AcquisitionCosts		usd
	us-gaap	Notes Reduction NotesReduction		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired		usd
	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense		usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards		usd
CY2023Q3	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-11596
	dei	Entity Registrant Name EntityRegistrantName	LONGWEN GROUP CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-3506403
	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 25
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Caihe Rd
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Shangcheng Dist.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Hangzhou
	dei	Entity Address Country EntityAddressCountry	CN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	310000
	dei	City Area Code CityAreaCode	86 0571
	dei	Local Phone Number LocalPhoneNumber	85128985
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79825094	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5638	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68121	usd
CY2023Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	378155	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	39303	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13695	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58413	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	436791	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	126534	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	250419	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	274370	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2911	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3625	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1132	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1132	usd
CY2023Q3	us-gaap	Assets Assets	691253	usd
CY2022Q4	us-gaap	Assets Assets	405661	usd
CY2023Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	39118	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	483130	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31962	usd
CY2023Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	82181	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12250	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	147982	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	90494	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	713293	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	134706	usd
CY2023Q3	us-gaap	Liabilities Liabilities	713293	usd
CY2022Q4	us-gaap	Liabilities Liabilities	134706	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79825094	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79825094	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74108926	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74108926	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	7983	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7411	usd
CY2023Q3	lwlw	Common Stock Issuable CommonStockIssuable	37	usd
CY2023Q3	lwlw	Deferred Compensation Sharebased DeferredCompensationSharebased	74000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20002164	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19285539	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19959957	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19027835	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1733	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5840	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-22040	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270955	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	691253	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	405661	usd
CY2022Q3	lwlw	Consulting Service Income ConsultingServiceIncome	11328	usd
	lwlw	Consulting Service Income ConsultingServiceIncome	15004	usd
	lwlw	Consulting Service Income ConsultingServiceIncome	19307	usd
	lwlw	Online Product Sales OnlineProductSales	6082	usd
CY2023Q3	lwlw	Offline Product Sales OfflineProductSales	548851	usd
	lwlw	Offline Product Sales OfflineProductSales	1972127	usd
CY2023Q3	us-gaap	Revenues Revenues	548851	usd
CY2022Q3	us-gaap	Revenues Revenues	11328	usd
	us-gaap	Revenues Revenues	1993213	usd
	us-gaap	Revenues Revenues	19307	usd
	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses	2199	usd
CY2023Q3	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses	550116	usd
	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses	1836512	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	550116	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1838711	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-1265	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	11328	usd
	us-gaap	Gross Profit GrossProfit	154502	usd
	us-gaap	Gross Profit GrossProfit	19307	usd
CY2023Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	61806	usd
CY2022Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	30011	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	168001	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	111346	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	125774	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21379	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	337095	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104181	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	576000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	187580	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	51390	usd
	us-gaap	Operating Expenses OperatingExpenses	1081096	usd
	us-gaap	Operating Expenses OperatingExpenses	215527	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-188845	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-40062	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-926594	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-196220	usd
CY2023Q3	lwlw	Interest Expense1 InterestExpense1	-104	usd
CY2022Q3	lwlw	Interest Expense1 InterestExpense1	-47	usd
	lwlw	Interest Expense1 InterestExpense1	-260	usd
	lwlw	Interest Expense1 InterestExpense1	-375	usd
CY2023Q3	us-gaap	Other Income OtherIncome	-174	usd
CY2022Q3	us-gaap	Other Income OtherIncome	-188	usd
	us-gaap	Other Income OtherIncome	-2010	usd
	us-gaap	Other Income OtherIncome	28	usd
CY2023Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-278	usd
CY2022Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-235	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2270	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-347	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-189123	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-40297	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-928864	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-196567	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3258	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-189123	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-40297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-932122	usd
	us-gaap	Net Income Loss NetIncomeLoss	-196567	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	3673	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2255	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4107	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	157	usd
CY2023Q3	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	3673	usd
CY2022Q3	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	2255	usd
	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	-4107	usd
	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	157	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-185450	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38042	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-936229	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-196410	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79825094	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65936163	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78996477	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65606270	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Net Income Loss NetIncomeLoss	-932122	usd
	us-gaap	Net Income Loss NetIncomeLoss	-196567	usd
	us-gaap	Depreciation Depreciation	9645	usd
	us-gaap	Depreciation Depreciation	1328	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	576000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	392588	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	40803	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-43864	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	81280	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	471988	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	375	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-264016	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-276144	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7753	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	7	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7746	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	83640	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	86741	usd
	us-gaap	Proceeds From Loans ProceedsFromLoans	211415	usd
	us-gaap	Proceeds From Loans ProceedsFromLoans	287876	usd
	lwlw	Repayments Of Loans From Shareholder Loans RepaymentsOfLoansFromShareholderLoans	-33132	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	-123710	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	-75757	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	67234	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	278357	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	205447	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	577217	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3914	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-21229	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-62483	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	272098	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68121	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5638	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	272098	usd
	us-gaap	Acquisition Costs AcquisitionCosts	993	usd
	us-gaap	Notes Reduction NotesReduction	14050	usd
	us-gaap	Stock Issued1 StockIssued1	23221	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	265178	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	163410	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3673	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-189123	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-22040	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270955	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	576000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	67234	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4107	usd
	us-gaap	Profit Loss ProfitLoss	-932122	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-22040	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	18807	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	87632	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2255	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	265178	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-40297	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	333575	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-13550	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	278357	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	265178	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	157	usd
	us-gaap	Profit Loss ProfitLoss	-196567	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	333575	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 750
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	127061	shares
	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	66667	shares
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	65000000	shares
CY2022Q4	us-gaap	Acquisition Costs AcquisitionCosts	1000
CY2022Q4	us-gaap	Acquisition Costs AcquisitionCosts	141	usd
CY2022Q4	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	139	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zyLb681smjV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p> <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zfvvPuSbh1M6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Concentration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended September 30, 2023, the Company generated 45%, 24% and 18% of revenues from the top 3 customers, respectively. During the nine months ended September 30, 2023, the Company generated 47%, 13% and 13% of revenues from the top 3 customers, respectively. The Company’s cost of revenues consisted of 88% and 92% purchases from one top vendor for the three and nine months ended September 30, 2023, respectively. The Company’s revenue and cost of revenues were not material during the three and nine months ended September 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 1pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p>
	us-gaap	Net Income Loss NetIncomeLoss	-932122	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19959957	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7008	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7419	usd
CY2023Q3	us-gaap	Land Land	256314	usd
CY2022Q4	us-gaap	Land Land	271319	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12903	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4368	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	250419	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	274370	usd
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2651780	shares
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	265178	usd
CY2023Q3	lwlw	Value Added Tax Payable ValueAddedTaxPayable	2108	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	263070	usd
CY2023Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	3118	usd
CY2022Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	598	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	9645	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	1328	usd
CY2023Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	82181	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12250	usd
CY2019Q4	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	300	usd
CY2023Q1	us-gaap	Notes Reduction NotesReduction	14050	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	47	usd
	us-gaap	Interest Expense InterestExpense	375	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	-123710	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	-870000
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20000000.0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19000000.0	usd
CY2023Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	826721	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	630975	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	826721	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	630975	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	39716	usd
CY2022Q3	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	8462	usd
	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	195746	usd
	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	41279	usd
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79825094	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74108926	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	278357	usd
	us-gaap	Asset Acquisition Price Of Acquisition Expected AssetAcquisitionPriceOfAcquisitionExpected	265178	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10000000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4250000	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	425000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	500000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	200000	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	550000	shares
CY2023Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	180000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	36000	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	74000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	370000	shares
CY2023Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	39118	usd

Files In Submission

Name	View Source	Status
0001017386-23-000399-index-headers.html	Edgar Link	pending
0001017386-23-000399-index.html	Edgar Link	pending
0001017386-23-000399.txt	Edgar Link	pending
0001017386-23-000399-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lwlw-20230930.xsd	Edgar Link	pending
lwlw_2023sept30-10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
lwlw-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lwlw-20230930_def.xml	Edgar Link	unprocessable
lwlw-20230930_pre.xml	Edgar Link	unprocessable
lwlw-20230930_lab.xml	Edgar Link	unprocessable
lwlw_2023sept30-10q_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WYGC
Longwen Group Corp. Stock $wygc

2023 Q4 Form 10-Q Financial Statement

#000101738623000399 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYGC Longwen Group Corp. Stock $wygc

2023 Q4 Form 10-Q Financial Statement

#000101738623000399 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYGC
Longwen Group Corp. Stock $wygc